Follow TIS on Twitter: @Truth_is_Scary & Like TIS of Facebook- facebook.com/TruthisScary
There is no plant on Earth more condemned than marijuana. We’re talking about a living organism which governments have taken upon themselves to designate as an illegal substance. Despite no existing evidence of anyone ever dying of a marijuana overdose, possession of this plant is still illegal in many parts of the world. Marijuana has been found to suppress cancer, reduce blood pressure, treat glaucoma, alleviate pain and even inhibit HIV. It is an antioxidant, anti-inflammatory and neuroprotective. Can you understand more now why it’s illegal? No Independent Study Has Ever Linked Marijuana To Psychosocial Problems
Cannabis is one of the most powerful healing plants on the planet. Dozens of studies have made pseudoscientific attempts to indicate that young people who use cannabis tend to experience psychological, social problems and mental decline. However, there is no evidence that marijuana use is directly linked with such problems, according to the results of a study published in The Lancet.
“Currently, there is no strong evidence that use of cannabis of itself causes psychological or social problems,” such as mental illness or school failure, lead study author Dr. John Macleod of the University of Birmingham in the UK told Reuters Health. “There is… evidence that cannabis use is associated with these things, but this association could have several explanations,” he said, citing factors such as adversity in early life, which may itself be associated with cannabis use and psychosocial problems.
Macleod and his team reviewed 48 long-term studies, 16 of which provided the highest quality information about the association between illicit drug use reported by people 25 years old or younger and later psychological or social problems. Most of the drug-specific results involved cannabis use. Cannabis use was not consistently associated with violent or antisocial behavior, or with psychological problems.
Notably, recent studies have shown CBD, a compound in cannabis, to be an effective atypical anti-psychotic in treating schizophrenia, a disease many other studies have inconsistently claimed cannabis to cause.
In another study, Scientists from King’s College, London, found occasional pot use could actually improve concentration levels. The study, carried in the American Journal of Epidemiology, tested the mental function and memory of nearly 9,000 Britons at age 50 and found that those who had used illegal drugs as recently as in their 40s did just as well, or slightly better, on the tests than peers who had never used drugs.
“Overall, at the population level, the results seem to suggest that past or even current illicit drug use is not necessarily associated with impaired cognitive functioning in early middle age,” said lead researcher Dr Alex Dregan.
Dr Dregan’s team used data on 8,992 42-year-olds participating in a UK national health study, who were asked if they had ever used any of 12 illegal drugs. Then, at the age of 50, they took standard tests of memory, attention and other cognitive abilities. Overall, the study found, there was no evidence that current or past drug users had poorer mental performance. In fact, when current and past users were lumped together, their test scores tended to be higher.
The Age of Deception is Ending
In 2003, the U.S. Government as represented by the Department of Health and Human Services filed for, and wasawarded a patent on cannabinoids. The reason? Because research into cannabinoids allowed pharmaceutical companies to acquire practical knowledge on one of the most powerful antioxidants and neuroprotectants known to the natural world.
The U.S. Patent 6630507 was specifically initiated when researchers found that cannabinoids had specific antioxidant properties making them useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.